Johnson & Johnson to Boost U.S. Spending by 25% with $55B and Four Plants
Johnson & Johnson will raise U.S. investments by 25%, totaling $55 billion over next four years and build four manufacturing plants, including sites in Wilson and Holly Springs, North Carolina. The company plans to spend $1 billion on a Pennsylvania cell therapy facility as part of its U.S. expansion drive.
1. Increased U.S. Investment
Johnson & Johnson will raise U.S. investments by 25%, allocating $55 billion over the next four years to expand domestic manufacturing capacity.
2. New Manufacturing Plants
The company plans to build four additional manufacturing plants, including facilities in Wilson and Holly Springs, North Carolina, as part of its long-term U.S. expansion strategy extending over the next decade.
3. Cell Therapy Facility
JNJ has committed more than $1 billion to construct a new cell therapy manufacturing facility in Pennsylvania to support growing demand in advanced biologics and bolster its domestic supply chain.